These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11803360)

  • 1. Large granular lymphocytes (LGL) following non-myeloablative allogeneic bone marrow transplantation: a case report.
    Mohty M; Faucher C; Gaugler B; Vey N; Sainty D; Arnoulet C; Mozziconacci MJ; Isnardon D; Gastaut JA; Maraninchi D; Olive D; Blaise D
    Bone Marrow Transplant; 2001 Dec; 28(12):1157-60. PubMed ID: 11803360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell large granular lymphocyte leukemia of donor origin after allogeneic bone marrow transplantation.
    Au WY; Lam CC; Lie AK; Pang A; Kwong YL
    Am J Clin Pathol; 2003 Oct; 120(4):626-30. PubMed ID: 14560574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells.
    Zorn E; Wang KS; Hochberg EP; Canning C; Alyea EP; Soiffer RJ; Ritz J
    Clin Cancer Res; 2002 Jul; 8(7):2052-60. PubMed ID: 12114403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Features of large granular lymphocytes (LGL) expansion following allogeneic stem cell transplantation: a long-term analysis.
    Mohty M; Faucher C; Vey N; Chabannon C; Sainty D; Arnoulet C; Gaugler B; Gastaut JA; Maraninchi D; Olive D; Blaise D
    Leukemia; 2002 Oct; 16(10):2129-33. PubMed ID: 12357367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell large granular lymphocytic leukemia of donor origin occurring after allogeneic bone marrow transplantation for B-cell lymphoproliferative disorders.
    Chang H; Kamel-Reid S; Hussain N; Lipton J; Messner HA
    Am J Clin Pathol; 2005 Feb; 123(2):196-9. PubMed ID: 15842042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association with the presence of naive T cells in chronic myeloid leukemia patients after allogeneic human stem cell transplantation and the lower incidence of chronic graft-versus host disease and relapse.
    Wysoczanska B; Bogunia-Kubik K; Dlubek D; Jaskula E; Sok A; Drabczak-Skrzypek D; Sedzimirska M; Lange A
    Transplant Proc; 2007 Nov; 39(9):2898-901. PubMed ID: 18022011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease- or therapy-related bone marrow damage cannot be overcome by changes in stem cell source or dose in allogeneic transplantation.
    Novotny JR; Rosenthal C; Elmaagacli AH; Dürig J; Beelen DW; Dührsen U
    Eur J Haematol; 2004 Jul; 73(1):1-9. PubMed ID: 15182331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Second transplant from the same donor without conditioning for bone marrow aplasia after non-myeloablative hematopoietic stem cell transplantation for chronic myeloid leukemia].
    Ishikawa I; Miyamura K; Yamada M; Sasaki O; Harigae H; Kameoka J; Meguro K; Sasaki T
    Rinsho Ketsueki; 2005 Dec; 46(12):1288-92. PubMed ID: 16447801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resolution of psoriasis following allogeneic bone marrow transplantation for chronic myelogenous leukemia: case report and review of the literature.
    Kanamori H; Tanaka M; Kawaguchi H; Yamaji S; Fujimaki K; Tomita N; Fujisawa S; Ishigatsubo Y
    Am J Hematol; 2002 Sep; 71(1):41-4. PubMed ID: 12221673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced-intensity conditioning for the treatment of malignant and life-threatening non-malignant disorders.
    Slavin S; Aker M; Shapira MY; Resnick I; Bitan M; Or R
    Clin Transpl; 2003; ():275-82. PubMed ID: 15387119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential thrombocythemia after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Khoury H; Adkins D; Zehnbauer B; Goodnough L; Brown R; Safdar S; DiPersio JF
    Bone Marrow Transplant; 1998 Jul; 22(1):107-9. PubMed ID: 9678805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of T-cell repertoire was useful for predicting graft-versus-host disease prognosis in a patient with chronic myelogeneous leukemia after allogeneic bone marrow transplantation.
    Tsutsumi Y; Tanaka J; Minami H; Musashi M; Fukushima A; Kawamura T; Kanamori H; Obara S; Noto S; Ogura N; Asaka M; Imamura M; Masauzi N
    Transplant Proc; 2004 Dec; 36(10):3200-2. PubMed ID: 15686728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic blood stem cell transplantation in chronic myeloid leukaemia-chronic phase following conditioning with busulphan and cyclophosphamide: a follow up report.
    Saikia TK; Parikh PM; Tawde S; Amare-Kadam PS; Rajadhyaksha S; Chhaya S
    Natl Med J India; 2004; 17(2):71-3. PubMed ID: 15141598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of dynamic detection of WT1 expression on monitoring minimal residual disease in leukemia patients following allogeneic bone marrow transplantation].
    Gu WY; Chen ZX; Hu SY; Zhu J; Wang ZL; Yan F; Wang W; Cen JN; Shen HL; Qian J
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):444-7. PubMed ID: 15854547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic haemopoietic stem cell transplantation using non-myeloablative conditioning--a local experience.
    Leong CF; Cheong SK; Fadilah SA; Ainoon O; Hamidah NH
    Med J Malaysia; 2003 Jun; 58(2):229-35. PubMed ID: 14569743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of an allogeneic non-myeloablative stem cell transplantation program in patients with chronic myelogenous leukemia.
    Ruiz-Argüelles GJ; Gómez-Almaguer D; López-Martínez B; Cantú-Rodríguez OG; Jaime-Pérez JC; González-Llano O
    Haematologica; 2002 Aug; 87(8):894-6. PubMed ID: 12161373
    [No Abstract]   [Full Text] [Related]  

  • 18. Transplantation of allogeneic CD34+-selected cells followed by early T-cell add-backs: favorable results in acute and chronic myeloid leukemia.
    Kobbe G; Fenk R; Neumann F; Bernhardt A; Steidl U; Kondakci M; Graef T; Aivado M; Vaupel M; Huenerlituerkoglu AN; Kronenwett R; Pape H; Hildebrand B; Germing U; Haas R
    Cytotherapy; 2004; 6(6):533-42. PubMed ID: 15764020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia.
    Molldrem JJ; Lee PP; Wang C; Felio K; Kantarjian HM; Champlin RE; Davis MM
    Nat Med; 2000 Sep; 6(9):1018-23. PubMed ID: 10973322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The graft-versus-leukemia effect of nonmyeloablative stem cell allografts may not be sufficient to cure chronic myelogenous leukemia.
    Sloand E; Childs RW; Solomon S; Greene A; Young NS; Barrett AJ
    Bone Marrow Transplant; 2003 Nov; 32(9):897-901. PubMed ID: 14561990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.